CFRX Shares Outstanding History



Below is a table of the CFRX shares outstanding history going back to 9/11/2014:

Date CFRX Shares Outstanding
9/11/201425099
9/12/201425099
11/14/201425272
3/19/201525286
5/11/201525401
8/10/201531350
11/9/201534353
3/9/201634355
5/5/201634357
8/8/201651924
11/7/201651974
3/7/201752070
5/2/201752070
8/8/201792070
11/9/201792070
3/7/201892070
8/7/201899262
11/8/201899262
3/7/201999262
5/7/201999262
8/7/201999262
11/7/201999262
2/4/202099262
3/9/2020191651
5/6/2020191651
8/6/2020347617
11/6/2020347626
3/24/2021491652
5/10/2021491659
8/10/2021491659
11/10/2021491659
3/17/2022491659
5/10/2022491659
8/12/2022491659
3/24/20231.57M
8/10/202310.70M

Also see: CFRX Market Cap History
CFRX YTD Return
CFRX Historical Shares Outstanding:
+97.20% CAGR
CFRX Historical Shares Outstanding: +97.20% CAGR

Mouse over chart for data details
9/11/2014 ...8/10/2023
ContraFect is a clinical-stage biotechnology company focused on the discovery and development of direct lytic agents (DLA), including lysins and amurin peptides, as new medical modalities for the treatment of antibiotic-resistant infections. Co.'s main DLA product candidate, exebacase, is being developed in patients with chronic prosthetic joint infections of the knee due to S. aureus or coagulase-negative Staphylococci. Co.'s other product candidate, CF-370, is designed to target gram-negative bacteria, including P. aeruginosa, K. pneumoniae and A. baumannii, and is effective in vivo activity against these pathogens, even against multidrug-resistant and extensively drug-resistant strains. We show 36 historical shares outstanding datapoints in our coverage of CFRX's shares outstanding history.

Understanding the changing numbers of CFRX shares outstanding — and comprehending the concept of differing number of shares outstanding in general comparing companies like CFRX versus peers — is critical for investors. Many "beginner" or "novice" investors will look at one stock trading at a price of $10 per share and another trading at a price of $20 per share and think the latter company is worth twice as much. Of course, that is a completely meaningless comparison without also knowing how many shares outstanding there are for each of the two companies. Furthermore, via issuance of new shares over time, or the repurchase of existing shares, the number of shares outstanding can fluctuate over the course of history. With this page we aim to empower investors researching CFRX by allowing them to research CFRX shares outstanding history as well as any other stock in our coverage universe.
Quotes delayed 20 minutes

Email EnvelopeFree CFRX Email Alerts:
Get Dividend Alerts
Get SEC Filing Alerts
10 ETFs With Stocks That Insiders Are Buying
10 ETFs With Most Upside To Analyst Targets
The DividendRank Top 25
Warren Buffett Dividend Stocks
10 Cheap Dividend Stocks Under $10
10 Energy Stocks You Can Buy Cheaper Than Insiders Did
10 Top DividendRank'ed Energy Stocks
The 10 Highest Yielding Preferred Stocks
The 10 Highest Yielding Preferred Stocks
The 15 Most Active Call & Put Options of the S&P 500 Components
Video: Shares Outstanding Importance


If the video does not load after a few moments, Upgrade to the Latest Flash Player.
ContraFect (CFRX) is categorized under the Healthcare sector; to help you further research historical shares outstanding numbers, below are some other companies in the same sector:

CGEM Shares Outstanding History
CGEN Shares Outstanding History
CGIX Shares Outstanding History
CGNT Shares Outstanding History
CGTX Shares Outstanding History
CHE Shares Outstanding History
CHFS Shares Outstanding History
CHMA Shares Outstanding History
CHRS Shares Outstanding History
CI Shares Outstanding History
More Healthcare companies »

 

CFRX Shares Outstanding History | www.SharesOutstandingHistory.com | Copyright © 2017 - 2024, All Rights Reserved

Nothing in SharesOutstandingHistory.com is intended to be investment advice, nor does it represent the opinion of, counsel from, or recommendations by BNK Invest Inc. or any of its affiliates, subsidiaries or partners. None of the information contained herein constitutes a recommendation that any particular security, portfolio, transaction, or investment strategy is suitable for any specific person. All viewers agree that under no circumstances will BNK Invest, Inc,. its subsidiaries, partners, officers, employees, affiliates, or agents be held liable for any loss or damage caused by your reliance on information obtained. By visiting, using or viewing this site, you agree to the following Full Disclaimer & Terms of Use and Privacy Policy. Video widget and market videos powered by Market News Video. Quote and option data delayed at least 15 minutes; stock quote data powered by Ticker Technologies, and Mergent.
X
Wait! Don't leave yet.
Want to receive our latest research absolutely free?


Click the button below for your complimentary copy of Your Early Retirement Portfolio: Dividends Up to 9.5%—Every Month—Forever.

You'll discover the details on 4 stocks and funds that pay you massive dividends as high as 9.5%.